Oslo - Delayed Quote NOK
Aqua Bio Technology ASA (ABTEC.OL)
0.7240
-0.0460
(-5.97%)
As of May 8 at 3:43:40 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
106,556.6560
106,556.6560
18,405.7190
7,016.7520
1,559.7030
Cost of Revenue
104,543.8650
104,543.8650
8,336.0350
4,689.0130
951.7760
Gross Profit
2,012.7910
2,012.7910
10,069.6840
2,327.7390
607.9270
Operating Expense
124,890.2970
124,890.2970
39,353.1890
23,039.1630
18,465.0710
Operating Income
-122,877.5060
-122,877.5060
-29,283.5050
-20,711.4240
-17,857.1440
Net Non Operating Interest Income Expense
-19,437.6390
-19,437.6390
-4,746.5410
-2,235.2290
-1,455.2010
Pretax Income
-345,165.2890
-345,165.2890
-20,845.2830
-18,751.6770
-19,112.7640
Tax Provision
-7,814.6080
-7,814.6080
178.5670
-16.0990
0
Net Income Common Stockholders
-337,350.6810
-337,350.6810
-21,023.8490
-18,735.5780
-19,112.7640
Average Dilution Earnings
--
--
0
-435.2430
--
Diluted NI Available to Com Stockholders
-337,350.6810
-337,350.6810
-21,023.8490
-19,170.8210
-19,112.7640
Basic EPS
-4.96
-4.96
-0.69
-0.91
-0.99
Diluted EPS
-4.96
-4.96
-0.69
-0.91
-0.99
Basic Average Shares
68,049.9230
68,049.9230
30,540.1440
20,692.5200
19,264.2800
Diluted Average Shares
68,049.9230
68,049.9230
30,540.1440
20,781.6480
19,264.2800
Total Operating Income as Reported
-325,714.3030
-325,714.3030
-15,784.7920
-16,367.8960
-17,857.1450
Rent Expense Supplemental
4,249.9860
4,249.9860
42.1760
1,166.1010
825.9940
Total Expenses
229,434.1620
229,434.1620
47,689.2240
27,728.1760
19,416.8470
Net Income from Continuing & Discontinued Operation
-337,350.6810
-337,350.6810
-21,023.8490
-18,735.5780
-19,112.7640
Normalized Income
-139,106.1468
-139,106.1468
-31,552.8444
-23,079.1080
-19,112.7640
Interest Income
301.6590
301.6590
55.3210
2.2120
0
Interest Expense
19,008.3630
19,008.3630
4,489.6830
2,237.4410
1,455.2010
Net Interest Income
-19,437.6390
-19,437.6390
-4,746.5410
-2,235.2290
-1,455.2010
EBIT
-326,156.9260
-326,156.9260
-16,355.6000
-16,514.2360
-17,657.5630
EBITDA
-314,422.4600
-314,422.4600
-12,670.7100
-14,845.5570
-16,567.4430
Reconciled Cost of Revenue
104,543.8650
104,543.8650
8,336.0350
4,689.0130
951.7760
Reconciled Depreciation
11,734.4660
11,734.4660
3,684.8900
1,668.6790
1,090.1200
Net Income from Continuing Operation Net Minority Interest
-337,350.6810
-337,350.6810
-21,023.8490
-18,735.5780
-19,112.7640
Total Unusual Items Excluding Goodwill
-202,836.7980
-202,836.7980
13,498.7120
4,343.5300
--
Total Unusual Items
-202,836.7980
-202,836.7980
13,498.7120
4,343.5300
--
Normalized EBITDA
-111,585.6620
-111,585.6620
-26,169.4220
-19,189.0870
-16,567.4430
Tax Rate for Calcs
0
0
0.0002
0
0
Tax Effect of Unusual Items
-4,592.2638
-4,592.2638
2,969.7166
0
0
12/31/2021 - 1/10/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade